EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Uncommon Histological Variants are Associated With Early Biochemical Recurrence After Robot-Assisted Radical Prostatectomy: A Retrospective Study With Exploratory Analysis of Postoperative PSA Outcomes

Peimin Zhou, Xu Chen, Meng Zhang, Shasha Hu, Mingwei Ma, Cheng Shen, Wei Yu

Clinical Genitourinary Cancer · 2026-08 · 24 (5) · 102575

DOI: 10.1016/j.clgc.2026.102575 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Genitourinary Cancer, 2026-08. Verfasst von Peimin Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Peking University First Hospital, Beijing, China; Institute of Urology, Peking University, Beijing, China; The National Urolog…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Prostatectomy, Prostate-Specific Antigen, Robotic Surgical Procedures. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Beijing Xisike Clinical Oncology Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: To evaluate the impact of uncommon histological (UH) variants on oncological outcomes after robot-assisted radical prostatectomy (RARP) in localized prostate cancer. PATIENTS AND METHODS: 809 patients who underwent RARP between January 2019 and January 2024 were analyzed. Patients were classified into pure adenocarcinoma (PAC) and various UH subgroups, including glomeruloid structure, neuroendocrine (NE) differentiation, sarcomatoid differentiation, signet ring-like cells (SRC), mucinous feature, and cribriform architecture. The primary endpoint was biochemical recurrence (BCR)-free survival. Secondary endpoints included PSA persistence, overall survival, and treatment response after BCR. Kaplan-Meier and Cox regression analyses were performed. RESULTS: At a median follow-up of 15 months, patients with NE/SRC/sarcomatoid differentiation had significantly higher BCR rates than those with PAC (42.9% vs. 13.5%, P < .05) and a lower 5-year BCR-free survival (HR 4.28; 95% CI, 2.10-8.72; P < .05). Following BCR, UH patients had longer time to PSA suppression (8.0 vs. 5.0 months, P < .05), though PSA ≤ 0.006 ng/mL was achieved in 80.0% of UH patients and 68.6% of PAC patients. CONCLUSIONS: UH variants in localized prostate cancer were associated with heterogeneous postoperative outcomes after RARP. The adverse prognostic effect was mainly driven by NE/SRC/sarcomatoid differentiation, which was associated with earlier BCR. Exploratory postoperative treatment analyses suggest that short-term biochemical control may be observed in some patients with UH variants, but these findings require cautious interpretation and further validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsProstatectomyProstate-Specific AntigenRobotic Surgical ProceduresNeoplasm Recurrence, LocalAdenocarcinomaHumansMaleRetrospective StudiesAgedMiddle AgedTreatment OutcomePrognosis

Stichwörter der Autor:innen

BCRPSA responseProstate cancerTreatment responseUnconventional histological variants

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • Department of Urology, Peking University First Hospital, Beijing, China; Institute of Urology, Peking University, Beijing, China; The National Urological Cancer Center of China, Beijing, China.
  • Department of Radiation Oncology, Peking University First Hospital, Beijing, China.
  • Department of Urology, Peking University First Hospital, Beijing, China; Institute of Urology, Peking University, Beijing, China; The National Urological Cancer Center of China, Beijing, China. Electronic address: shenc…
  • Department of Urology, Peking University First Hospital, Beijing, China; Institute of Urology, Peking University, Beijing, China; The National Urological Cancer Center of China, Beijing, China. Electronic address: yuwei…

Förderung

  • Beijing Xisike Clinical Oncology Research Foundation

Zitieren

APA

Zhou, P., Chen, X., Zhang, M., Hu, S., Ma, M., Shen, C., & Yu, W. (2026). Uncommon Histological Variants are Associated With Early Biochemical Recurrence After Robot-Assisted Radical Prostatectomy: A Retrospective Study With Exploratory Analysis of Postoperative PSA Outcomes. Clinical Genitourinary Cancer, 24(5), 102575. https://doi.org/10.1016/j.clgc.2026.102575

Vancouver

Zhou P, Chen X, Zhang M, Hu S, Ma M, Shen C, et al. Uncommon Histological Variants are Associated With Early Biochemical Recurrence After Robot-Assisted Radical Prostatectomy: A Retrospective Study With Exploratory Analysis of Postoperative PSA Outcomes. Clinical Genitourinary Cancer. 2026;24(5):102575. doi:10.1016/j.clgc.2026.102575

BibTeX
@article{Zhou2026,
  author = {Zhou, Peimin and Chen, Xu and Zhang, Meng and Hu, Shasha and Ma, Mingwei and Shen, Cheng and Yu, Wei},
  title = {Uncommon Histological Variants are Associated With Early Biochemical Recurrence After Robot-Assisted Radical Prostatectomy: A Retrospective Study With Exploratory Analysis of Postoperative PSA Outcomes},
  journal = {Clinical Genitourinary Cancer},
  year = {2026},
  volume = {24},
  number = {5},
  pages = {102575},
  doi = {10.1016/j.clgc.2026.102575}
}
Kostenlos starten →